OTC : CRWRF

Craneware plc

$15.23 USD

-$0.97 (-5.99%)

Volume
500
Average Volume
50
Market Capitalization
$521.43M
P/E Ratio
24.72
Dividend Yield
2.89%
Price Target
Year High
$34.00
Year Low
$15.23
Day High
—
Day Low
—
Payout Ratio
$0.66
Current Ratio
$0.76
Company Overview

OTC

Keith Neilson

Medical - Healthcare Information Services

Healthcare

CRWRF

747

GB

USD

https://www.craneware.com

44 13 1550 3100

N/A

0001486727

Liquidity Metrics

0.08

0.76

0.76

0.31

0.66

Sales & Valuation

$205.66M

2.52

1.61

55.05

0.28

Profitability

$0.55

$19.66M

10.63%

12.71%

6.65%

4.28%

P/E Metrics

24.72

0.53

0.53

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

3.67

7/9

-$32.11M

$526.4M

$186.48M

$49.95M

Key Metrics (TTM)

$509.46M

2.40

10.70

0.76

6.65%

6.10%

4.20%

1.85%

$11.82

72 days

Company Executives
Name Title
Tara Hanuscak Chief Transformation Officer
Ian Armstrong Chief Growth Officer
Craig Thomas Preston Chief Financial Officer, Company Secretary & Executive Director
Isabel Urquhart Chief People Officer & Director
Derek William Paterson Chief Information Officer
Abhilesh Gandhi Group Chief Technology Officer
Keith Neilson Co-Founder, Chief Executive Officer & Executive Director
Eric Carter Chief Legal Officer
Lidia A. Rodriguez-Hupp Chief Customer Officer
Jill Goldsmith Company Secretary
Poll Results

No votes yet today — be the first to share your view!

About Craneware plc (OTC:CRWRF) Stock

Craneware plc, alongside its various subsidiaries, is dedicated to developing, licensing, and providing ongoing support for specialized software solutions within the United States healthcare industry. The company's comprehensive suite of products addresses a wide range of operational and financial needs. For revenue cycle and financial management, Craneware offers Trisus pricing transparency software, designed to clarify pricing information, along with Trisus Pricing Analyzer to automate and simplify price modeling. Its Trisus Chargemaster provides automated management of chargemaster data, while InSight Audit assists government and commercial payors with audit processes. Additionally, InSight Denials facilitates the analysis, tracking, and reporting of claims denial data, and Trisus Claim ... s Informatics offers retrospective analytical insights to identify charge capture risks. In the realm of clinical operations and supply chain, solutions include InSight Medical Necessity, which helps U.S. payors determine medical necessity; Trisus Supply, aimed at enhancing reimbursement for medical supplies; and Trisus Healthcare Intelligence, delivering patient-level insights into resource consumption. The portfolio also extends to Trisus Medication Analytic and Trisus Supplies Assistant solutions. Craneware also features a specialized line of pharmacy and drug tracking software. This includes Sentinel for drug tracking, Sentrex (a SaaS platform enabling covered entities to expand medication access), Sentrex 330, a Referral Verification System, and Sentry Core, which streamlines the complexities of pharmacy procurement, utilization, and compliance. Beyond its software offerings, Craneware provides professional and appeal services. The company was founded in 1999 and is headquartered in Edinburgh, United Kingdom.

Craneware reveals cyber attack with employee and customer data stolen

2026-07-20 02:44:57

Craneware PLC (AIM:CRW) has disclosed a cyber security incident in which hackers gained unauthorised access to part of its data environment and stole employee, customer and partner records. The Edinburgh-based healthcare financial performance software firm said a significant volume of file names were viewed and taken, though its current assessment is that much of the data involved is non-sensitive or already public regulatory information.

Craneware shares slump after slower conversion triggers profit warning

2026-07-03 06:04:48

Craneware PLC (AIM:CRW) shares slumped 18%, trading down to 1,192p, after the firm warned full-year revenue and earnings will fall below market expectations after 340B pharmacy-related opportunities converted into recognised revenue more slowly than anticipated in the final weeks of the financial year. The healthcare financial performance software group said revenue for the year to 30 June 2026 is expected to be between US$205mln and US$208mln, while adjusted EBITDA is forecast at US$65mln to US$67mln.

Frequently Asked Questions

What is the current Craneware plc (CRWRF) stock price?

Craneware plc(OTC:CRWRF) stock price is $15.23 in the last trading session. During the trading session, CRWRF stock reached the peak price of $34 while $15.23 was the lowest point it dropped to. The percentage change in CRWRF stock occurred in the recent session was --5.99% while the dollar amount for the price change in CRWRF stock was -$0.97.

CRWRF's industry and sector of operation?

The OTC listed CRWRF is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.

Who are the executives of CRWRF?

Tara Hanuscak | Chief Transformation Officer
Ian Armstrong | Chief Growth Officer
Craig Thomas Preston | Chief Financial Officer, Company Secretary & Executive Director
Isabel Urquhart | Chief People Officer & Director
Derek William Paterson | Chief Information Officer

How many employees does CRWRF have?

Number of CRWRF employees currently stands at 747. CRWRF operates from 1 Tanfield, Edinburgh, SC EH3 5DA, GB.

Link for CRWRF official website?

Official Website of CRWRF is: https://www.craneware.com

How do I contact CRWRF?

CRWRF could be contacted at phone #44 13 1550 3100 and can also be accessed through its website. CRWRF operates from 1 Tanfield, Edinburgh, SC EH3 5DA, GB.

How many shares of CRWRF are traded daily?

The average number of CRWRF shares traded daily for last 3 months was 50.

What is the market cap of CRWRF currently?

The market value of CRWRF currently stands at $521.43M with its latest stock price at $15.23